147 related articles for article (PubMed ID: 11117779)
1. Keratin immunohistochemistry detects clinically significant metastases in bone marrow biopsy specimens in women with lobular breast carcinoma.
Lyda MH; Tetef M; Carter NH; Ikle D; Weiss LM; Arber DA
Am J Surg Pathol; 2000 Dec; 24(12):1593-9. PubMed ID: 11117779
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow granulomas in infiltrating lobular breast cancer.
Kettle P; Allen DC
J Clin Pathol; 1997 Feb; 50(2):166-8. PubMed ID: 9155702
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone.
Bitter MA; Fiorito D; Corkill ME; Huffer WE; Stemmer SM; Shpall EJ; Archer PG; Franklin WA
Hum Pathol; 1994 Aug; 25(8):781-8. PubMed ID: 7520018
[TBL] [Abstract][Full Text] [Related]
4. Sentinel Lymph Nodes in Classic Invasive Lobular Carcinoma of the Breast: Cytokeratin Immunostain Ensures Detection, and Precise Determination of Extent, of Involvement.
Patel A; D'Alfonso T; Cheng E; Hoda SA
Am J Surg Pathol; 2017 Nov; 41(11):1499-1505. PubMed ID: 28877063
[TBL] [Abstract][Full Text] [Related]
5. Does the method of biopsy affect the incidence of sentinel lymph node metastases?
Newman EL; Kahn A; Diehl KM; Cimmino VM; Kleer CA; Chang AE; Newman LA; Sabel MS
Breast J; 2006; 12(1):53-7. PubMed ID: 16409587
[TBL] [Abstract][Full Text] [Related]
6. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
[TBL] [Abstract][Full Text] [Related]
7. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
[TBL] [Abstract][Full Text] [Related]
8. [Tubulolobular carcinoma of breast: a clinicopathologic study of 8 cases].
Shi J; Liang ZY; Meng ZL; Luo YF; Cao JL; Yang CM; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):681-5. PubMed ID: 23302310
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
10. Keratin immunohistochemistry does not contribute to correct lymph node staging in patients with invasive lobular carcinoma.
Patil DT; Susnik B
Hum Pathol; 2008 Jul; 39(7):1011-7. PubMed ID: 18400255
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.
Langer I; Guller U; Worni M; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Viehl C; Bronz L; Schnarwyler B; Wight E; Infanger E; Burger D; Koechli OR; Zuber M;
Ann Surg Oncol; 2014 Feb; 21(2):401-7. PubMed ID: 24145993
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast.
Creager AJ; Geisinger KR; Perrier ND; Shen P; Shaw JA; Young PR; Case D; Levine EA
Ann Surg; 2004 Jan; 239(1):61-6. PubMed ID: 14685101
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
Fields KK; Elfenbein GJ; Trudeau WL; Perkins JB; Janssen WE; Moscinski LC
J Clin Oncol; 1996 Jun; 14(6):1868-76. PubMed ID: 8656255
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
17. The role of wide-spectrum cytokeratin staining of the bone marrow cores in patients with ductal carcinoma of the breast.
Dunphy CH
Mod Pathol; 1996 Oct; 9(10):955-8. PubMed ID: 9005447
[TBL] [Abstract][Full Text] [Related]
18. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.
Crisi GM; Mandavilli S; Cronin E; Ricci A
Am J Surg Pathol; 2003 Mar; 27(3):325-33. PubMed ID: 12604888
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.
Vannucchi AM; Bosi A; Glinz S; Pacini P; Linari S; Saccardi R; Alterini R; Rigacci L; Guidi S; Lombardini L; Longo G; Mariani MP; Rossi-Ferrini P
Br J Haematol; 1998 Dec; 103(3):610-7. PubMed ID: 9858208
[TBL] [Abstract][Full Text] [Related]
20. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?
Trocciola SM; Hoda S; Osborne MP; Christos PJ; Levin H; Martins D; Carson J; Daly J; Simmons RM
J Am Coll Surg; 2005 May; 200(5):720-5; discussion 725-6. PubMed ID: 15848362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]